KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer

Clinical trial NCT04034823 · UNKNOWN

Trial details

NCT number: NCT04034823
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2019-09-01
Primary completion: 2021-01-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.